Toronto, Canada

Eleftherios P Diamandis

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Biomarker Detection. Top assignees: Nordion International Inc., Mount Sinai Hospital Corporation, Visible Genetics Inc.. Active years: 1992-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eleftherios P Diamandis. Retrieved from https://idiyas.com/inventor/eleftherios-p-diamandis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 68.4

 

 

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 1992-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biomarkers
Prostate-Specific Antigen
Ovarian Cancer
Alzheimer's Disease
Kallikrein Gene
Fluorometric Assays
Detection Methods
Screening Techniques
Immunoassays
Genetic Markers
Tumor Detection
Endocrine Cancer
19 patents (USPTO):Explore Patents

Title: **The Innovations of Eleftherios P Diamandis: Pioneering Advances in Urogenital Health**

Introduction

Eleftherios P Diamandis is a notable inventor based in Toronto, Canada, known for his significant contributions to medical diagnostics and urogenital health. With a prolific portfolio of 18 patents, Diamandis has been at the forefront of developing innovative methods for detecting urogenital conditions.

Latest Patents

His latest patents focus on "Markers of the Male Urogenital Tract," where he describes methods for detecting urogenital conditions or status in a subject. These innovations encompass the measurement of urogenital markers or polynucleotides in samples from subjects. The inventions also include localization or imaging methods for urogenital conditions and kits designed to facilitate the implementation of these methods. Additionally, the patents contemplate therapeutic applications for urogenital conditions using markers, polynucleotides encoding the markers, and binding agents specifically designed for these markers.

Career Highlights

Throughout his career, Eleftherios P Diamandis has worked with prestigious organizations such as Nordion International Inc. and Mount Sinai Hospital Corporation. His roles in these companies have allowed him to refine his expertise and push the boundaries of medical technology, significantly impacting patient care and urogenital health diagnostics.

Collaborations

Diamandis has collaborated with esteemed professionals, including George M Yousef and Russell Redshaw. These collaborations have fostered an environment of innovation and have contributed to the development of essential medical technologies that address critical health concerns.

Conclusion

Eleftherios P Diamandis stands as a remarkable figure in the realm of medical innovation, with a keen focus on urogenital health. His extensive patent portfolio and collaborative efforts reflect his dedication to enhancing diagnostic approaches and therapeutic options, ultimately aiming to improve health outcomes in this crucial area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…